5-Amino-1MQ
A small-molecule inhibitor of nicotinamide N-methyltransferase, an enzyme involved in nicotinamide metabolism and studied in the context of adipose tissue.
Any compounds discussed may be intended for research purposes only. Nothing here is a protocol to follow — amounts, timing and cycle lengths are reported as the named speaker described them.
We are not doctors. Use at your own risk.
Overview
5-Amino-1MQ is a small molecule rather than a peptide, grouped here because it is discussed alongside metabolic peptides. It inhibits nicotinamide N-methyltransferase (NNMT), an enzyme expressed in adipose tissue and liver.
Interest follows from rodent work in which NNMT inhibition was associated with changes in fat mass. That work is preclinical. Published human trials are not available, and the compound has no regulatory approval in any jurisdiction.
What the research examines
Rodent studies of NNMT inhibition and its relationship to adipose tissue metabolism. The question of whether any of it translates to humans is open and largely untested.
Reported protocols
Attributed to the person who described them. Amounts, timing and interactions as stated on air.
Nobody has described a protocol for 5-Amino-1MQ on the show. When someone does, it will appear here attributed to them.
Adverse effects
No human safety data has been published. The absence of reported effects reflects the absence of trials, not a finding of safety.
Presentation and storage
Typically supplied as a powder for research use. Storage conditions vary by supplier and are not standardised.
Discussed in
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
Learn
New episode alerts, every week
The episode, its chapters and every source cited, straight to your inbox. No fluff. No spam.